AR096980A1 - CYCLIC POLIPEPTIDES FOR THE CARDIAC INSUFFICIENCY TREATMENT - Google Patents
CYCLIC POLIPEPTIDES FOR THE CARDIAC INSUFFICIENCY TREATMENTInfo
- Publication number
- AR096980A1 AR096980A1 ARP140102680A ARP140102680A AR096980A1 AR 096980 A1 AR096980 A1 AR 096980A1 AR P140102680 A ARP140102680 A AR P140102680A AR P140102680 A ARP140102680 A AR P140102680A AR 096980 A1 AR096980 A1 AR 096980A1
- Authority
- AR
- Argentina
- Prior art keywords
- polypeptides
- heart failure
- cyclic
- diabetes
- polipeptides
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un polipéptido cíclico de la fórmula (1): X¹-R-X³-X⁴-L-S-X⁷-X⁸-X⁹-X¹⁰-X¹¹-X¹²-X¹³ (1) o una amida, un éster o una sal del mismo, o un bioconjugado del mismo, en donde X¹, X³, X⁴, X⁷, X⁸, X⁹, X¹⁰, X¹¹, X¹² y X¹³ se definen en la presente. Los polipéptidos son agonistas del receptor APJ. Un método para la fabricación de los polipéptidos o bioconjugados de los mismos, y sus usos terapéuticos tales como el tratamiento o la prevención de insuficiencia cardiaca aguda descompensada (IDAC), insuficiencia cardiaca crónica, hipertensión pulmonar, fibrilación atrial, síndrome de Brugada, taquicardia ventricular, aterosclerosis, hipertensión, restenosis, enfermedades cardiovasculares isquémicas, cardiomiopatía, fibrosis cardiaca, arritmia, retención de agua, diabetes (incluyendo diabetes gestacional), obesidad, enfermedad arterial periférica, accidentes cerebrovasculares, ataques isquémicos temporales, lesiones cerebrales traumáticas, esclerosis lateral amiotrófica, lesiones por quemaduras (incluyendo quemaduras solares) y preeclampsia. Una combinación de agentes farmacológicamente activos y una composición farmacéutica.A cyclic polypeptide of the formula (1): X¹-R-X³-X⁴-LS-X⁷-X⁸-X⁹-X¹⁰-X¹¹-X¹²-X¹³ (1) or an amide, an ester or a salt thereof, or a bioconjugate thereof, wherein X¹, X³, X⁴, X⁷, X⁸, X⁹, X¹⁰, X¹¹, X¹² and X¹³ are defined herein. Polypeptides are agonists of the APJ receptor. A method for the manufacture of polypeptides or bioconjugates thereof, and their therapeutic uses such as the treatment or prevention of decompensated acute heart failure (IDAC), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia , atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, strokes, temporary ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. A combination of pharmacologically active agents and a pharmaceutical composition.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361858263P | 2013-07-25 | 2013-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR096980A1 true AR096980A1 (en) | 2016-02-10 |
Family
ID=56125378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140102680A AR096980A1 (en) | 2013-07-25 | 2014-07-21 | CYCLIC POLIPEPTIDES FOR THE CARDIAC INSUFFICIENCY TREATMENT |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR096980A1 (en) |
| MA (1) | MA38864A1 (en) |
-
2014
- 2014-07-21 MA MA38864A patent/MA38864A1/en unknown
- 2014-07-21 AR ARP140102680A patent/AR096980A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA38864A1 (en) | 2017-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR089808A1 (en) | APELINE SYNTHETIC MIMETICS FOR CARDIAC FAILURE TREATMENT | |
| CU20160013A7 (en) | CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE | |
| UY35144A (en) | APELINE SYNTHETIC LINEAR MIMETICS FOR THE CARDIAC INSUFFICIENCY TREATMENT | |
| EA201690282A1 (en) | BIOCONJUGATES OF SYNTHETIC ORANGE POLYPEPTIDES | |
| PE20151595A1 (en) | PIRAZOL-AMIDE COMPOUNDS AND THEIR PHARMACEUTICAL USES | |
| JP2014528901A5 (en) | ||
| AR103415A1 (en) | TREATMENT OF PEDIATRIC PATIENTS WITH MELLITUS DIABETES OF TYPE 2 | |
| CO7170176A2 (en) | New compound that has the ability to inhibit the enzyme dehydrogenase11b-hydroxysteroid type 1 (11b-hsd1) or pharmaceutically acceptable salt thereof, method of producing the same, and pharmaceutical composition containing the same as active ingredient | |
| BR112015021265A2 (en) | enhancement methods of use for recombinant human secretoglobins | |
| AR104479A1 (en) | CONJUGATES OF FATTY ACIDS AND SYNTHETIC APPEAL WITH GREATER HALF LIFE | |
| CL2013000021A1 (en) | Delta crystalline form of perindopril arginine salt; preparation procedure; pharmaceutical compositions containing it; and its use for the treatment of cardiovascular diseases, such as high blood pressure, heart failure or stable coronary heart disease. | |
| AR096980A1 (en) | CYCLIC POLIPEPTIDES FOR THE CARDIAC INSUFFICIENCY TREATMENT | |
| AR094018A1 (en) | FUNNY CURRENT INHIBITORS (IF) FOR USE IN A METHOD OF TREATMENT AND / OR PREVENTION OF CARDIAC DISEASE IN CANINOS | |
| JP2017502089A5 (en) | ||
| ECSP12011627A (en) | OTAMIXABAN FOR THE TREATMENT OF PATIENTS WITH RENAL ALTERATION AND ADVANCED AGE WITH INFARTO MIOCARDIO WITHOUT ELEVATION OF THE ST | |
| AR091984A1 (en) | SOLID ORAL COMPOSITION CONTAINING COLORS FOR USE IN ENDOSCOPIC DIAGNOSIS | |
| TN2016000029A1 (en) | Bioconjugates of synthetic apelin polypeptides | |
| EA201592261A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING AGOMELATIN IN THE FORM OF HOMELATIN CRYSTALS WITH ORGANIC ACID | |
| RU2010125488A (en) | METHOD FOR RESTORING SINUS RHYTHM AT TYPE ATRITION TYPE 1 | |
| TH146851A (en) | Synthetic amyloidosis for the treatment of heart failure | |
| JP2016513647A5 (en) | ||
| 秦树存 | Phospholipid transfer protein in diabetes, metabolic syndrome and obesity | |
| WO2014176567A3 (en) | Pharmaceutical compositions comprising vanoxerine and antianginal compounds, and methods of administration of the same for treating episodes of cardiac arrhythmia, maintaining normal sinus rhythm, preventing recurrence of cardiac arrhythmia, and treatment of chronic cardiac arrhythmia in mammals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |